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Abstract
Introduction
Persistent bacterial bronchitis (PBB) is a leading cause of chronic wet cough in young chil-
dren. This study aimed to characterise the respiratory bacterial microbiota of healthy chil-
dren and to assess the impact of the changes associated with the development of PBB.
Blind, protected brushings were obtained from 20 healthy controls and 24 children with
PBB, with an additional directed sample obtained from PBB patients. DNA was extracted,
quantified using a 16S rRNA gene quantitative PCR assay prior to microbial community
analysis by 16S rRNA gene sequencing.
Results
No significant difference in bacterial diversity or community composition (R2 = 0.01, P =
0.36) was observed between paired blind and non-blind brushes, showing that blind brush-
ings are a valid means of accessing the airway microbiota. This has important implications
for collecting lower respiratory samples from healthy children. A significant decrease in
bacterial diversity (P < 0.001) and change in community composition (R2 = 0.08, P = 0.004)
was observed among controls, in comparison with patients. Bacterial communities within
patients with PBB were dominated by Proteobacteria, and indicator species analysis
showed that Haemophilus and Neisseria were significantly associated with the patient
group. In 15 (52.9%) cases the dominant organism by sequencing was not identified by
standard routine clinical culture.
Conclusion
The bacteria present in the lungs of patients with PBB were less diverse in terms of richness
and evenness. The results validate the clinical diagnosis, and suggest that more attention to
bacterial communities in children with chronic cough may lead to more rapid recognition of
this condition with earlier treatment and reduction in disease burden.
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Introduction
Persistent or protracted bacterial bronchitis (PBB) is a leading cause of chronic wet cough last-
ing more than 4 weeks in young children. PBB is particularly common in pre-school children,
often developing after a viral lower respiratory infection [1, 2], but may present at any age. As
a result, PBB is often either misdiagnosed as asthma or the symptoms are dismissed as being
due to recurrent viral infection [1–3].
Standard treatment for PBB is high dose oral antibiotics, the cough typically taking 10–14
days to resolve [4]. Although the aim of therapy is to provide a definitive cure, reoccurrences
are frequent and if not treated successfully may lead to bronchiectasis [1–4].
Our understanding of the role of bacteria in chronic respiratory diseases is changing rap-
idly. Until recently it was widely believed that the healthy lung was a sterile environment [5]. A
growing body of evidence, however, indicates that the healthy airways have a resident micro-
biota which can vary between individuals [5–7] and can alter significantly as a result of respira-
tory diseases such as cystic fibrosis, COPD and asthma [8].
A previous study of children with PBB using 16S rRNA gene sequencing suggested that the
bacterial communities present in their lungs demonstrated similarities to those seen in chil-
dren with cystic fibrosis (CF) and non-CF bronchiectasis [9]. This study provided a useful
insight into the bacterial community associated with PBB, although the control subjects were
undergoing bronchoscopy for clinical indications and could not be considered to be healthy
[9–11].
In this present study bronchial brushings were obtained from infants and children with
a diagnosis of PBB and from healthy children who were free of any respiratory symptoms or
significant previous lower respiratory tract illness. This has given the opportunity for a better
understanding of the microbiota of the healthy airway in childhood, as well as insight into how
it is perturbed in children with PBB. In addition, the validity of characterising the lower air-
ways microbiome using blind brushings through an endotracheal tube as opposed to more
invasive bronchoscope guided sampling has been investigated.
Methods
All study protocols were subject to ethical approval by the Local Health Research Authority,
NRES Committee of Yorkshire & The Humber—South Yorkshire (Reference: 12/YH/0230).
Full details of sampling, laboratory and analytical methods are given in S1 Appendix, Supple-
mentary Methods.
The study subjects were all 17 years of age or younger. Written informed consent was taken
from the parents or legally acceptable representatives of children aged 15 years and younger or
from the patient themselves if 16 years or older. The study was conducted in accordance with
the International Conference for Harmonisation of Good Clinical Practice and the guiding
principles of the Declaration of Helsinki and the Research Governance Framework for Health
and Social Care. None of these subjects had an identified significant immunodeficiency or
other conditions.
Control subjects were recruited if they were undergoing an intervention requiring endotra-
cheal intubation but were otherwise healthy without any history of acute or chronic upper or
lower respiratory tracts symptoms.
Sixteen mothers of enrolled children aged 2 years had nasal and oropharyngeal (throat)
swabs taken (S1 Appendix, S1 Table). Written informed consent was collected and stored in
patient clinical records for all mothers enrolled in the study.
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Sample collection
Samples were obtained at the time of a diagnostic bronchoscopy for those with PBB and
opportunistically from healthy subjects undergoing planned surgical procedures. Blind brush-
ings were obtained in both groups using a protected cytology brush inserted into the airway
through an ET tube. In the PBB subjects a second sample was obtained via the bronchoscope
in order to compare the results from directed and blind brushings. After obtaining the brush-
ings, BAL was collected from all children with PBB for routine bacterial, fungal and viral
screening at the Sheffield children’s hospital clinical laboratories.
Once collected, brushes and swabs were immediately stored at -80˚C prior to further
processing.
DNA extractions
DNA was extracted from both swabs and brushes using the MPBio FastDNA™ spin kit for soil
as per the manufacturer’s instructions.
qPCR
Prior to sequencing total bacterial burden was measured using a quantitative PCR assay target-
ing the V4 region of the 16S rRNA gene and using the primers 520F, 5’- AYTGGGYDTAA
AGNG and 820R, 5’-TACNVGGGTATCTAATCC.
DNA sequencing
The bacterial community within each sample was assessed using 16S rRNA gene sequencing.
Dual barcoded fusion primers were used to target the previously quantified V4 region of the
gene (same primers as for qPCR assay but with appropriate barcoding. See S1 Appendix, S2
Table for barcode details). Samples were sequenced on the Illumina MiSeq platform using the
Illumina V2 2x250bp cycle kit. Sequences were submitted to the European nucleotide data-
base, project number PRJEB18478.
Downstream sequencing analysis was carried out using Quantitative Insights in Microbial
Ecology (QIIME) Version 1.9.0 [12]. The QIIME recommended minimum threshold of 1,000
reads was applied and samples with less than 1,000 reads were removed from further analysis.
All remaining samples were then rarefied to the same minimum number of reads present.
Statistics
All statistical analyses were carried out using R Version 3.2.2 [13]. Primary analysis and pre-
processing was carried out in Phyloseq [13]. Non-parametric Wilcoxon sign ranked tests were
used to test significant differences between means. DESeq2 [14] and Indicator species analysis
[15] were used to identify Operational Taxonomic Units (OTUs) significantly associated with
PBB.
Results
Twenty four children with PBB and 20 healthy controls were successfully recruited into the
study (Table 1). Nasal and throat swabs were obtained from mothers for 16 of the children; 11
of the PBB children and 5 of the healthy child controls.
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16S rRNA gene sequencing
A total of 146 samples were sequenced on the Illumina MiSeq. These included mock commu-
nities, PCR negative controls, kit controls and bronchoscopy brush controls (S2 Table).
After quality control 143 samples were included for further analysis, comprising of a total of
8,833,294 reads from 1,393 distinct OTUs (61,771.29 +/- 85,954.18 [mean +/- SD] number of
reads/OTU). Samples above the 1,000 read cut off recommended by QIIME were rarefied to
the minimum number of reads found in the samples.
Blind versus non-blind brush
PBB patients were sampled using both blind and non-blind brushing methods to test for
potential differences in the bacterial community due to sampling method. The difference in
the bacterial community of 21 paired samples were assessed using both alpha and beta diver-
sity measurements. Samples were rarefied to 1,067 reads. No significant difference in alpha
diversity was observed between the blind and non-blind brushes using richness (observed
number of species, Z = 1.843, P = 0.068), Shannon-Weiner (bias towards rare organisms,
Z = -0.017, P = 1), Simpsons reciprocal (bias toward more dominant organisms, Z = 0.261,
P = 0.812) and evenness (Z = -0.052, P = 0.973) (S1 Fig).
Considering community composition no significant differences were observed between
the different sampling methods (Adonis: R2 = 0.012, P = 0.344). Hierarchical clustering using
Bray-Curtis dissimilarity revealed that the samples clustered more closely between patients
than within sampling groups (Fig 1).
PBB versus healthy controls
The bacterial community of patients diagnosed with PBB (N = 24) was compared to healthy
controls (N = 18). Samples were rarefied to 1,150 reads, resulting in the loss of 2 control
patients. No difference in the bacterial abundance by qPCR was observed between the healthy
controls and PBB patients (R2 = 0.021, P = 0.511) (Fig 2). Investigation into alpha diversity
measures showed that PBB patients had a significantly lower diversity than the healthy controls
(S2 Fig). This was seen across all measures; the Wilcoxon rank sum test, richness (W = 100.5,
P = 0.001), Shannon-Weiner (W = 78, P< 0.001), Simpson’s reciprocal (W = 79, P< 0.001)
and evenness (W = 84, P< 0.001).
Differences in community composition were investigated using Bray-Curtis dissimilarity.
Adonis showed significant differences in community composition (R2 = 0.082, P = 0.001).
Table 1. Table of patient demographics for cases (PBB) and controls.
Cases Controls
Number of subjects 24 20
Female 14 12
Blind brush 24 21
Non-blind brush 24 N/A
Age in years, mean (min, max) 4.3 (0.8, 13.7) 7.4 (1, 15.8)
Breastfed, count (min, max months) 9 (0.07, 12) 11 (0.5, 24)
Antibiotics, weeks since last dose (min, max) 1, 25 4, 53
Mother smokes 2 4
Father smokes 5 10
Both parents smoke 2 4
Mother sampled 11 5
https://doi.org/10.1371/journal.pone.0190075.t001
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Hierarchical clustering using Bray-Curtis dissimilarity showed that the bacterial community
present in healthy controls clustered separately from those with PBB (Fig 2).
DESeq2 was used to identify OTUs significantly associated with PBB. Haemophilus
and Neisseria OTUs were identified as being significantly increased in patients with PBB
(P< 0.001) (S3 Fig). This result was backed up using indicator species analysis between the
PBB and control communities. Two OTUs were significantly associated with the PBB group,
Haemophilus_3673 (P = 0.043) and Neisseria_4022 (P = 0.05). Haemophilus_3673 was a
Fig 1. Ordered bar chart of the top 20 OTUs present in both the blind and non-blind brushings. Samples are ordered by a Bray Curtis
dissimilarity hierarchical cluster shown by the top plot. Key to colours used for each genus is included. Identical patient numbers indicate samples were
taken from the same individual. Sample type is indicated in the labelling beneath the graph with red indicating blind brush and blue indicating non-blind
brush.
https://doi.org/10.1371/journal.pone.0190075.g001
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member of the top 20 most abundant OTUs observed. The control group had 35 OTUs signifi-
cantly associated, 9 of which were included in the top 20 most abundant OTUs.
Comparing the results of standard clinical bacterial culture to the 16s rRNA gene sequenc-
ing results for the 24 PBB patients, 20 (83.33%) were culture positive. The four patients that
were culture negative were, by sequencing, dominated either by Moraxella, Neisseria or Hae-
mophilus OTUs. Whilst no patient cultured Neisseria, 5 of the patients were found to be
Fig 2. Ordered bar chart of the top 20 OTUs present in both the PBB and control subjects. Samples are ordered by a Bray Curtis dissimilarity
hierarchical cluster, upper plot. Key to colours used for each genus is included. Patient numbers are detailed in the lower plot where disease status is
also indicated by colour of the bars with red indicating PBB and blue indicates control subjects. Additionally lower bar plot indicates the log10 copies
per μl as calculated by qPCR. No significant difference was found between the qPCR values between the PBB and control patients (R2 = 0.023,
P = 0.445).
https://doi.org/10.1371/journal.pone.0190075.g002
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dominated by a Neisseria OTU from the sequencing results. Seventeen (70.83%) of the 24
patients cultured Haemophilus influenzae, while only 9 (52.94%) of the same patients were
found to be Haemophilus dominated by sequencing. Moraxella was cultured from 3 patients,
in two of the three Moraxella was found to be the dominant organism by sequencing. Another
2 patients, however, were dominated by the Moraxella OTU despite not being positive on cul-
ture for the bacterium. Only fifteen of the 24 patients (62.5%) cultured the dominant organism
that was identified by sequencing.
Neither parental smoking habits (R2 = 0.037, P = 0.145) or breastfeeding (R2 = 0.012,
P = 0.846) were found to influence the bacterial community differences between patients with
PBB and healthy controls.
To ascertain if wheeze explained any of the variation in the bacterial community observed
between patients, wheeze diagnosis was investigated. No significant difference was observed
between patients with and without wheeze (R2 = 0.048, P = 0.34) (S4 Fig). No control patients
were diagnosed with wheeze.
Impact of respiratory virus on bacterial composition
PBB patients were tested for the presence of respiratory viruses. The presence of a virus
(R2 = 0.166, P = 0.167) or number of different viruses present (R2 = 0.227, P = 0.095) in
patients had no significant effect on the bacterial community composition. None of the 6
respiratory viruses showed any significant effect on the bacterial community composition, rhi-
novirus (R2 = 0.057, P = 0.266), respiratory syncytial virus (RSV) (R2 = 0.048, P = 0.406), Coro-
navirus (R2 = 0.027, P = 0.844), human metapneumovirus (HMP) (R2 = 0.052, P = 0.314),
adenovirus (R2 = 0.008, P = 0.99), parainfluenza (R2 = 0.057, P = 0.259).
Sampling of mothers, throat swabs versus nose swabs
Mothers of 16 children (11 PBB cases and 6 healthy controls) were sampled using both nose
and throat swabs. To investigate if these sampling methods were comparable, samples were
rarefied to 1,154 reads (4 samples were lost after rarefaction) after which non-metric multidi-
mensional scaling (NMDS) using Bray-Curtis distance was used to investigate clustering based
on bacterial community similarity (S5 Fig).
Notably samples from the same mother did not cluster together (S6 Fig). No significant dif-
ference in Shannon-Weiner (Z = -0.44, P = 0.7) or Simpson’s reciprocal (Z = -1.24, P = 0.24)
diversity was observed between the two groups of samples nose versus throat swabs. There
was however a significant difference in richness (Z = 2.58, P< 0.01) with throat swabs having
more distinct OTUs than nose swabs. Additionally, bacterial abundance as determined by
qPCR was significantly higher in throat swabs compared to nasal swabs (Z = 2.84, P< 0.01)
(S6 Fig). Analysis by ADONIS confirmed these results, with 11% of the variation between sam-
ples being explained by the sample type (R2 = 0.11, P = 0.02).
Children and mothers
The bacterial community within the lung of children under the age of 2 years, both with
(N = 11) and without a PBB diagnosis (N = 5), was compared to the bacterial communities
present in the nose and throat of their mothers. Samples were rarefied to 1,067 reads. Neither
nose or throat swabs of mothers were found to have significantly different bacterial richness
compared to child communities using a Wilcoxon rank sum test, applied to independent sam-
ples (nose; richness, W = 111, P = 0.317, throat; richness, W = 164.5, P = 0.032). Significant dif-
ferences in both Shannon-Weiner and Simpson’s reciprocal were however observed between
the two groups (nose; Shannon-Weiner, W = 138, P = 0.019, Simpson’s reciprocal, W = 138,
The impact of PBB on the pulmonary microbiome
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P = 0.019; throat; Shannon-Weiner, W = 177, P = 0.007, Simpson’s reciprocal, W = 185,
P = 0.002). Adonis showed there was significant differences in community composition when
comparing between different sampling methods, while controlling for sample family (R2 =
0.182, P< 0.001), indicting that the upper respiratory tract from mothers is not comparable to
their children.
Bray-Curtis hierarchical clustering was used to detect any patterns of similarities in com-
munity composition between mothers and their children (Fig 3). Overall the samples collected
from the mothers compared to those from the PBB children were significantly different, how-
ever there was a single exception. The bacterial communities present in the throat swab of the
mother and the blind brush from the child of family 34 were found to have in common a high
abundance of Streptococcus, as well as Veillonella and Neisseria (S6 Fig).
Discussion
This study provides the first insight into the composition of the bacterial community present
within the lungs of both healthy infants and children and those with persistent bacterial bron-
chitis. Investigation into the bacterial community within the lungs of these children highlights
the impact of PBB on the lung microbiota and provides insight into disease progression.
Across a range of pulmonary diseases, including COPD, non-CF bronchiectasis and cystic
fibrosis, a reduction in the diversity and the appearance of dominant OTUs from potentially
pathogenic genera has been observed [16–20]. It is perhaps unsurprising therefore, that in the
present study a significant reduction in bacterial diversity associated with PBB was observed.
In this present study, Haemophilus, Neisseria, Streptococcus and Moraxella were all repre-
sented amongst the dominant OTUs in PBB samples, although DESeq2 and indicator species
analysis showed that only a Haemophilus and a Neisseria OTU were significantly associated
with PBB. This is likely to be due to the number of patients dominated in this particular sample
set (Fig 3). Importantly in many cases the dominant organisms by sequencing were not those
identified by culture, highlighting the potential limitations of traditional culture techniques
the results of which typically dictate therapeutic strategies. It has been previously observed that
conventional microbiology has the potential to miss the presence of potentially pathogenic
organisms [16, 21].
Sequencing identified a Neisseria OTU as dominant in a number of subjects in this study
yet culture failed to identify Neisseria in any patients. This failure to recognize organisms in
chronic airways diseases may account in part for the ‘negative’ culture results from BAL and
sputum samples that are frequently encountered in the presence of purulent secretions. This
may be of particular importance when it comes to Neisseria species, which are commonly
found to colonise the nasopharyngeal mucosa [22]. Despite many Neisseria species being con-
sidered non-pathogenic, they have been implicated in cases of pneumonia [23], periodontal
disease [22] and COPD [24].
No significant differences in the bacterial community of PBB patients whose parents were
smokers compared to non-smokers were found. However, due to the low number of individu-
als in this study we cannot exclude smoking having an effect on the bacterial communities of
children. It would be important to expand this research to include a much larger sample set to
investigate this further.
Wheeze is a common symptom associated with PBB [25], however in this dataset it was
only diagnosed in a subset of children suffering from PBB and not in controls. No difference
in the bacterial community was associated with a diagnosis of wheeze however, this may due
to insufficient power.
The impact of PBB on the pulmonary microbiome
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Fig 3. Ordered bar chart of the top 20 OTUs present in both the mother of study children less than 2 years old and their children. This
subgroup includes both healthy children (red) and those diagnosed with PBB (blue). Mothers are indicated in green. Samples are ordered by a Bray
Curtis dissimilarity hierarchical cluster, shown above. Key to colours used for each genus is included. Lower bar plot indicates the log10 copies per μl
as calculated by qPCR.
https://doi.org/10.1371/journal.pone.0190075.g003
The impact of PBB on the pulmonary microbiome
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In this study nose and throat samples were collected from mothers of children under 2
years old and compared with the results from the lower airways of their offspring. Nose swabs
from mothers were significantly different from their own throat swabs, showing that there are
major differences between these areas of the upper respiratory tract. Previous studies have
shown that unlike the nose the bacterial community from the throat is more similar to that of
the lower airways [11]. It was hypothesised that the bacterial community present in the respira-
tory tract of mothers and children would therefore potentially share similarities, due to their
close proximity and shared environments when children are under 2 years of age. In the
majority of cases however, the community composition of the mothers’ samples were signifi-
cantly different from their children. Only a single case was observed where the maternal oro-
pharyngeal community and their child’s lower airway bacterial communities were similar, and
these samples were found to be dominated by the same organism.
The inclusion of lower airway samples from healthy controls provides a challenge, particu-
larly in paediatric studies, due to the invasive nature of the sampling methods required to
access the lower respiratory tract. This has resulted in many paediatric studies either sampling
the upper respiratory tract [26] or including “controls” with other respiratory indications [9,
11]. Hilty et al. observed a decrease in the Proteobacteria and an increase in Bacteroidetes in
controls compared to asthmatics, although only 3 of their 7 controls had no respiratory symp-
toms [11]. The current study demonstrates that the data generated from a blind brushing via
an ET tube is comparable to that obtained by visualization using bronchoscopy, the so-called
non-blind brush, allowing the inclusion of healthy children attending the hospital for reasons
unrelated to respiratory symptoms.
This has important implications for future studies of the lower airways microbiota, particu-
larly those involving infants and children, as a non-invasive method will allow greater number
of subjects to be studied and affords the opportunity of conducting longitudinal studies with
more regular sampling.
Conclusion
In conclusion, the bacterial community within the lungs of children with PBB shows a signifi-
cantly lower diversity than that observed in healthy children. This is due to the high levels of
dominance of Haemophilus, Neisseria, Streptococcus and Moraxella. In many cases the domi-
nant organisms by sequencing were not those identified by culture. This study is the first step
in using next generation sequencing methods to increase our understanding of the bacterial
community within the lungs of children with PBB. These methods have the potential to lead to
quicker more effective treatments, reducing the risk of recurrence or disease progression.
Supporting information
S1 Appendix. Supplementary information. This file includes supplementary methods and
tables.
(DOCX)
S1 Table. Number of samples sequenced, including controls and repeats.
(DOCX)
S2 Table. Demographics of mothers sampled.
(DOCX)
S1 Fig. Comparison of community alpha diversity measures between blind and non-blind
brushes from PBB patients. Using a Wilcoxon paired sign rank test no significant difference
was observed between sampling methods. Richness; Z = 1.843, P = 0.068, Shannon-Weiner;
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Z = -0.017, P = 1, Simpsons; Z = 0.261, P = 0.812, evenness; Z = -0.052, P = 0.973.
(TIF)
S2 Fig. Differences in bacterial diversity between PBB patients and healthy controls. Using
a Wilcoxon sign rank test significant differences in richness (W = 90.5, P = 0.001), Shannon-
Weiner (W = 70, P< 0.001), Simpson’s reciprocal (W = 76, P< 0.001) and evenness (W = 65,
P< 0.001) were observed between the two groups.
(TIF)
S3 Fig. Volcano plot indicating the OTUs significantly increased in PBB patients
(P< 0.001). Grey points indicate OTUs with P> 0.001. Colours indicate OTU genus, while
size indicates the sum of the reads in each OTU. Significant OTUs showed a more than 2.5
fold increase in abundance compared to controls.
(TIF)
S4 Fig. Ordered bar chart of the top 20 OTUs present in PBB patients with and without a
diagnosis of wheeze. Samples are ordered by a Bray Curtis dissimilarity hierarchical cluster
upper plot with the lower plot indicating if patient has a diagnosis of wheeze. Key to colours
used for each genus is included.
(TIF)
S5 Fig. NMDS based of Bray-Curtis dissimilarity of the bacterial communities, rarefied to
1154 reads, recovered from both throat and nose swabs of participant mothers. Nose swabs
are indicated in blue, throat swabs are indicated in red. Mothers of PBB patients are indicated
by triangles while the mothers of controls are shown by circles.
(TIF)
S6 Fig. Ordered bar chart of the top 20 OTUs present in both paired throat and nose swabs
from mothers. Rarefaction resulted in the removal of some samples due to low sequence num-
bers, the paired samples from these patients were removed to allow paired analysis. Samples
are ordered by a Bray Curtis dissimilarity hierarchical cluster. Key to colours used for each
genus is included. Log10 copies of 16S rRNA gene per μl of sample is shown in the lower plot
with colour indicating sample type; blue being nasal swab and red being throat swab. Note:
missing data 25 (Mother of Patient 25 throat) and 29 (Mother of patient 29 nose) samples had
DNA concentrations below the detection limit of the qPCR assay.
(TIF)
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